Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Icahn Seeks to Narrow Forest Drug Research Focus in Battle for Board Seats
Bloomberg
Friday, August 12, 2011 - 8:21am
tags:
Forest Labs, Carl Icahn
AstraZeneca to Settle Idaho Medicaid Drug-Price Claims for $2.5 Million Q
Bloomberg
Friday, August 12, 2011 - 8:13am
tags:
Idaho, Medicaid, settlements, drug pricing, AstraZeneca
Earnings Miss for Osiris
Yahoo/Zacks.com
Friday, August 12, 2011 - 8:11am
tags:
Osiris, earnings
Amarin Gets 1 Step Closer to the Big Time
Motley Fool
Friday, August 12, 2011 - 8:10am
tags:
Amarin, fish oil, AMR101
Why Abbott Laboratories May Be About to Take Off
Motley Fool
Friday, August 12, 2011 - 8:10am
tags:
Abbott Laboratories
Pfizer-Icagen Deal: PFE's $56M Cash Offer for ICGN Beat Two Other Bids
Motley Fool
Friday, August 12, 2011 - 8:09am
tags:
Pfizer, Icagen, M&A
Teva Analysts Stick to ‘Buy’ Ratings as Stock Repays Love With 41% Decline
Bloomberg
Thursday, August 11, 2011 - 2:02pm
tags:
Teva Pharmaceuticals, analysts
Earnings Scorecard: Celgene Corporation
Seeking Alpha
Thursday, August 11, 2011 - 12:39pm
tags:
Celgene, earnings
In U.S. and Spain, pharma says price cuts will cost jobs
Fierce Pharma
Thursday, August 11, 2011 - 12:39pm
tags:
United States, Spain, layoffs
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thursday, August 11, 2011 - 12:37pm
tags:
biotech, drug approvals, FDA, Eyelea, Regeneron, Dendreon, Provenge, NuPathe, Zelrix, Adcetris, Seattle Genetics, Soliris, Alexion, Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, EXPAREL, Pacira, Roche, Zelboraf, Iluvien, Alimera, Bio-T-Gel, Teva Pharmaceuticals, BioSante, Zevalin, Spectrum, ruxolitinib, Incyte, Novartis, Pfizer, crizotinib, Antares, Anturol, Bydureon, Amlyin, Eli Lilly, Alkermes, AZ-004, Alexza, Corlux, Corcept Therapeutics, Affymax, Takeda, peginesatide, Levadex, MAP Pharmaceuticals
Ampio Provides a Healthcare Sector Opportunity Amid a Tantrum of Selling
Seeking Alpha
Thursday, August 11, 2011 - 12:30pm
tags:
Ampio Pharmaceuticals
How Pfizer Saved Millions by Dumping Its Retirees on Medicare
BNET Pharma
Thursday, August 11, 2011 - 11:21am
tags:
Pfizer, retirement, Medicare
Gilead Sciences resolves FDA warning letter
Yahoo/AP
Thursday, August 11, 2011 - 11:20am
tags:
FDA, warnings, Gilead, antifungals, AmBisome
Par, Actavis Group Sued by Avanir Over Nuedexta Patents
Bloomberg
Thursday, August 11, 2011 - 11:17am
tags:
Par, Actavis, Avanir, patents, generics, Nuedexta, PBA
MAP Pharmaceuticals issued migraine treatment patent
Bizjournals.com
Thursday, August 11, 2011 - 11:14am
tags:
MAP Pharmaceuticals, patents, migraines
Venture Investing In Biotech Continues To Drop
Pharmalot
Thursday, August 11, 2011 - 11:13am
tags:
biotech, venture capital
Pfizer has begun payouts to victims, families over fatal 1996 meningitis drug study in Nigeria
Yahoo/AP
Thursday, August 11, 2011 - 11:12am
tags:
Nigeria, settlements, meningitis, Pfizer, Trovan
Analyst sees low physician expectations for new Gilead HIV treatment Complera
Yahoo/AP
Thursday, August 11, 2011 - 11:10am
tags:
Gilead, HIV, Complera, JNJ, Atripla, Bristol-Myers Squibb
Paladin makes hostile bid for Afexa
Fierce Biotech
Wednesday, August 10, 2011 - 8:36pm
tags:
Afexa, Paladin, hostile bid, M&A
Forest Labs says firms support its board nominees
Yahoo/AP
Wednesday, August 10, 2011 - 7:37pm
tags:
Forest Labs, Carl Icahn

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.